T: +44 (0) 1794 301052 E: info@ploughshareinnovations.com

Pre-symptomatic Determination of Sepsis

Determine the onset of sepsis days before clinical symptoms appear in the patient.

Diagnosed cases of sepsis exceed 18 million a year with 1,400 patients dying daily in the developed world. Rapid treatment is critical to a patient’s recovery and therefore the time taken to diagnose sepsis is key. This technology can diagnose sepsis in the patient before symptoms appear which has the potential to save many lives and reduce economic costs.

Benefits

  • Therapeutic window extended and mortality rates reduced
  • Cost of treatment lowered
  • Can discriminate between sepsis, SIRS, and negative controls
  • Compatible with RT-qPCR formats for rapid results

Licensing

For more information about licensing this technology, or to speak to us about our other life sciences related intellectual property, please contact us

About Ploughshare Innovations: harnessing innovation for a better world

Ploughshare is your gateway to a portfolio of world-class life science and other technology solutions from Dstl, the MOD’s research and development division.